儿科药学杂志2024，Vol.30Issue(1)：27-32,6.DOI:10.13407/j.cnki.jpp.1672-108X.2024.01.008
我国儿童药品研发的政策支持及立项考虑
Policy Support and Project Considerations for Pediatric Drug Development in China
周平 1金永华 1李超1
作者信息
- 1. 江苏开元药业有限公司,南京 210000
- 折叠
摘要
Abstract
Objective:The current issues in children's medication are prominent in China,characterized by a limited variety of suitable drugs,a lack of appropriate dosage forms and specifications for children,and off-label drug use.In recent years,drug regulatory authorities have issued multiple support policies and guiding principles for pediatric drug development in China,leading to an increasing enthusiasm for research and development among enterprises.This article reviews the relevant supporting policies for domestic pediatric drug development,attempts to propose directions for the initiation of pediatric drug projects from the perspective of enterprises,and analyzes the issues that need attention in research and development initiation.关键词
儿童/药品研发/政策Key words
children/drug development/policy分类
医药卫生引用本文复制引用
周平,金永华,李超..我国儿童药品研发的政策支持及立项考虑[J].儿科药学杂志,2024,30(1):27-32,6.
